Gunma, Japan

Mikio Yagi

This inventor holds 1 USPTO granted patent. Top assignee: Kirin Beer Kabushiki Kaisha. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikio Yagi. Retrieved from https://idiyas.com/inventor/mikio-yagi-jt0dinpc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mikio Yagi: Innovator in Medicinal Chemistry

Introduction

Mikio Yagi is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on isoxazole and thiazole compounds.

Latest Patents

Mikio Yagi holds a patent for "Isoxazole and thiazole compounds and use thereof as medicine." This invention relates to novel compounds that exhibit excellent lysophosphatidic acid (LPA) receptor antagonistic activity. The compounds are represented by a general formula that includes various substituents, allowing for a range of applications in medicine.

Career Highlights

Yagi is associated with Kirin Beer Kabushiki Kaisha, where he applies his expertise in medicinal chemistry. His work has contributed to advancements in pharmaceutical research and development.

Collaborations

Mikio Yagi collaborates with talented coworkers, including Akihiro Ueno and Rika Nagao. Their combined efforts enhance the innovative environment at their workplace.

Conclusion

Mikio Yagi's contributions to medicinal chemistry through his patented inventions highlight his role as a significant inventor in the field. His work continues to influence the development of new medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…